RENAISSANCE TECHNOLOGIES LLC

Position in IGC — IGC Pharma, Inc.

CIK 1037389 NEW YORK, NY

Position in IGC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$77,384

-$48,449 QoQ

Shares Held

286,608

-40.8% QoQ

Ownership

0.277%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 33 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,560,012 across 312 Biotechnology names. IGC ranks #280 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$77,384	286,608	-40.8%	Shares	Sole	2026-08-13
2026-03-31	$125,833	483,975	-47.4%	Shares	Sole	2026-05-14
2025-12-31	$257,499	919,641	-24.6%	Shares	Sole	2026-02-12
2025-09-30	$511,965	1,218,965	+2115.3%	Shares	Sole	2025-11-13
2025-06-30	$17,057	55,025	-61.1%	Shares	Sole	2025-08-13
2024-03-31	$56,521	141,303	+62.6%	Shares	Sole	2024-05-13
2023-09-30	$31,284	86,902	-46.6%	Shares	Sole	2023-11-14
2023-06-30	$50,439	162,709	+47.5%	Shares	Sole	2023-08-11
2023-03-31	$37,502	110,300	-50.3%	Shares	Sole	2023-05-12
2022-12-31	$71,043	222,011	-30.8%	Shares	Sole	2023-02-13
2022-09-30	$137,987	320,900	+47.4%	Shares	Sole	2022-11-14
2022-06-30	$115,406	217,749	-50.1%	Shares	Sole	2022-08-12
2021-09-30	$646,464	436,800	+46.5%	Shares	Sole	2021-11-12
2021-06-30	$488,908	298,115	+169.5%	Shares	Sole	2021-08-13
2020-09-30	$115,046	110,622	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.